These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7520248

  • 1. Comparison of the immune response to recombinant gp120 in humans and chimpanzees.
    Berman PW, Eastman DJ, Wilkes DM, Nakamura GR, Gregory TJ, Schwartz D, Gorse G, Belshe R, Clements ML, Byrn RA.
    AIDS; 1994 May; 8(5):591-601. PubMed ID: 7520248
    [Abstract] [Full Text] [Related]

  • 2. Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines.
    Coëffier E, Girard M, Barré-Sinoussi F, Meignier B, Muchmore E, Fultz PN, LeClerc C.
    AIDS Res Hum Retroviruses; 1998 Aug 10; 14(12):1023-34. PubMed ID: 9718117
    [Abstract] [Full Text] [Related]

  • 3. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
    Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M.
    AIDS Res Hum Retroviruses; 1991 Oct 10; 7(10):813-23. PubMed ID: 1720628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
    Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R.
    JAMA; 1994 Aug 10; 272(6):475-80. PubMed ID: 7913731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.
    Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS.
    J Virol; 1992 Jan 10; 66(1):172-82. PubMed ID: 1727480
    [Abstract] [Full Text] [Related]

  • 9. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.
    Newman MJ, Wu JY, Gardner BH, Anderson CA, Kensil CR, Recchia J, Coughlin RT, Powell MF.
    Vaccine; 1997 Jun 10; 15(9):1001-7. PubMed ID: 9261947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.
    Gorse GJ, Patel GB, Newman FK, Belshe RB, Berman PW, Gregory TJ, Matthews TJ.
    Clin Diagn Lab Immunol; 1996 Jul 10; 3(4):378-86. PubMed ID: 8807200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules.
    VanCott TC, Bethke FR, Kalyanaraman V, Burke DS, Redfield RR, Birx DL.
    J Acquir Immune Defic Syndr (1988); 1994 Nov 10; 7(11):1103-15. PubMed ID: 7523653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.